Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Induction of human trophoblast stem-like cells from primed pluripotent stem cells. | Proc Natl Acad Sci U S A | 2022 | 35537047 | PubTator, text mining | PubMed |
| An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy. | Biol Direct | 2022 | 35534873 | PubTator, text mining | PubMed |
| Upregulation of B7-H4 Is Involved in and Related to the Severity of Acute Pancreatitis. | J Interferon Cytokine Res | 2022 | 35533007 | PubTator, text mining | PubMed |
| Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2022 | 35528973 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Analysis Based on Public Databases for Constructing a Metastasis-Related Prognostic Model for Gastric Cancer. | Appl Bionics Biomech | 2022 | 35528539 | PubTator, text mining | PubMed |
| Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming. | Curr Opin Pharmacol | 2022 | 35526340 | PubTator, text mining | PubMed |
| The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy. | Nat Commun | 2022 | 35523809 | PubTator, text mining | PubMed |
| Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer. | Front Genet | 2022 | 35518357 | PubTator, text mining | PubMed |
| Mapping Breast Cancer Microenvironment Through Single-Cell Omics. | Front Immunol | 2022 | 35514975 | PubTator, text mining | PubMed |
| Soluble B7H3 level in breast cancer and its relationship with clinicopathological variables and T cell infiltration. | Contemp Oncol (Pozn) | 2022 | 35506036 | PubTator, text mining | PubMed |
| Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature. | Cancer Med | 2022 | 35505641 | PubTator, text mining | PubMed |
| B7-H4 reduction induced by Toxoplasma gondii infection results in dysfunction of decidual dendritic cells by regulating the JAK2/STAT3 pathway. | Parasit Vectors | 2022 | 35505420 | PubTator, text mining | PubMed |
| HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy. | J Clin Invest | 2022 | 35499076 | PubTator, text mining | PubMed |
| Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers. | Front Immunol | 2022 | 35493526 | PubTator, text mining | PubMed |
| Clinical Significance of the Expression of Co-Stimulatory Molecule B7-H3 in Papillary Thyroid Carcinoma. | Front Cell Dev Biol | 2022 | 35493085 | PubTator, text mining | PubMed |
| Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis. | Pathol Res Pract | 2022 | 35489125 | PubTator, text mining | PubMed |
| Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature. | J Transl Med | 2022 | 35468826 | PubTator, text mining | PubMed |
| Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy. | Front Oncol | 2022 | 35463369 | PubTator, text mining | PubMed |
| Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. | Sci Rep | 2022 | 35459272 | PubTator, text mining | PubMed |
| Dissecting Tumor-Immune Microenvironment in Breast Cancer at a Spatial and Multiplex Resolution. | Cancers (Basel) | 2022 | 35454904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=44